What Are Biostimulators and How Do They Work?

If you’ve spent any time around aesthetic clinics lately, you’ll have heard the word “biostimulator” (sometimes written “bio-stimulator”) more and more. Some people describe it as the next big thing in skin rejuvenation. Others say it’s just a new name for something practitioners have used for years. The truth sits somewhere in the middle.

In this guide we’ll explain what biostimulators are, how they work in the skin, how they compare with traditional dermal fillers, and what practitioners should consider before adding them to their treatment menu. We’ll cover the benefits and the limitations, so you can make an informed decision.

What Is a Biostimulator?

A biostimulator is an injectable product designed to prompt the skin’s own cells to produce new structural proteins, mainly collagen. Traditional fillers mostly work by adding volume directly. Biostimulators work more indirectly: they act as a trigger, and the body does much of the rebuilding.

Put simply, a hyaluronic acid (HA) filler is like filling a hole with material. A biostimulator is more like calling in a repair crew and letting them build over time.

The term isn’t tightly regulated, and it gets used to cover several different product types. Most practitioners use it for one of four main categories:

• Poly-L-lactic acid (PLLA)
• Calcium hydroxylapatite (CaHA)
• Polycaprolactone (PCL)
• Poly-D,L-lactic acid (PDLLA)

Polynucleotides and some other skin-quality injectables are sometimes grouped in here too. We’ll come back to that below, because it’s a grey area.

Why Has Interest in Biostimulators Grown?

There are a few reasons the category has gained ground in recent years:

1. Patients want natural-looking results. Many patients say they’re wary of the “overfilled” look and prefer gradual, subtle improvement.
2. Skin quality is now a treatment goal in its own right. Practitioners increasingly treat firmness, texture and laxity, not just lost volume or lines.
3. Longer-lasting options appeal. Products that build results over time and last well beyond a typical HA filler appeal to both patients and clinics.
4. Understanding of ageing has moved on. We now think of facial ageing as a combination of volume loss, bone resorption, fat pad changes and declining collagen and elastin, not only wrinkles.

How Do Biostimulators Actually Work?

The exact biology varies between products, but the general principle is similar across the category.

Step 1: The product is placed in the skin or at depth

Depending on the product, the practitioner injects it into the deep dermis, the subdermal plane, or a deeper plane (for example, supraperiosteal). Technique and depth matter a lot. Placing a product too superficially is a common cause of complications with several biostimulators.

Step 2: The body responds to the material

Once injected, the body recognises the particles or microspheres as something foreign. This starts a controlled, low-grade inflammatory response. Immune cells, particularly macrophages, arrive at the site. This is not a fault in the treatment. It’s the intended mechanism.

Step 3: Fibroblasts are activated

As part of this response, fibroblasts, the cells responsible for producing collagen and other structural components, are stimulated. Over the following weeks and months, they lay down new collagen (mainly type I and type III) and other extracellular matrix components.

Step 4: The product is gradually broken down or remains as a scaffold

What happens next depends on the material:

1. PLLA is a biodegradable synthetic polymer. It’s gradually broken down and metabolised by the body over time, while the new collagen it triggered remains.
2. CaHA consists of microspheres suspended in a carrier gel. The gel is absorbed within the first weeks, and the microspheres act as a scaffold for new tissue, then break down into calcium and phosphate ions.
3. PCL microspheres in a carrier gel also act as a scaffold. PCL degrades slowly, and different formulations are designed to last for different lengths of time.
4. PDLLA is another biodegradable polymer that stimulates collagen production, generally with a shorter degradation time than PLLA.

Step 5: Results build gradually

Because the body is doing the work, results aren’t immediate. You may see some initial volume from the carrier or fluid, but this often fades within days. The real change comes over weeks to months as collagen builds up. This is one of the biggest differences from HA fillers, and it’s important to explain clearly to patients.

The Main Types of Biostimulators Explained

Poly-L-lactic acid (PLLA)

PLLA has a long history in both medicine (it’s been used in resorbable sutures) and aesthetics. It’s typically supplied as a powder that must be reconstituted before use, and reconstitution and dilution protocols matter for both results and safety.

• Best known for: Gradual volume restoration and improving skin quality
• Typical protocol: Usually multiple sessions spaced several weeks apart
• Duration: Results are often reported to last up to around two years, though this varies between patients
• Things to consider: Delayed-onset nodules are a recognised risk, so technique, dilution and post-treatment massage guidance are important

Calcium hydroxylapatite (CaHA)

CaHA is a mineral compound that occurs naturally in bone and teeth. In aesthetics it’s supplied as a pre-mixed gel with microspheres.

• Best known for: Providing some immediate volume alongside collagen stimulation
• Duration: Commonly around 12 to 18 months, though it varies
• Things to consider: It’s used both undiluted for structural support and in diluted or hyperdiluted forms for skin quality and laxity. Diluted and hyperdiluted uses are often off-label or beyond the manufacturer’s instructions, so practitioners should understand the evidence and their professional and insurance position.

Polycaprolactone (PCL)

PCL is another biodegradable polymer, used in microsphere form suspended in a gel carrier.

• Best known for: Immediate volume plus long-term collagen stimulation
• Duration: Different formulations are designed for different timeframes, in some cases several years
• Things to consider: Longer-lasting products need careful patient selection and technique, because problems can persist longer too

Poly-D,L-lactic acid (PDLLA)

PDLLA is a newer entrant in many markets. Products in this category tend to be aimed at skin quality, texture and mild laxity.

• Best known for: Skin-quality improvement using a fine, easily injected suspension
• Things to consider: Long-term data is more limited than for PLLA and CaHA, so practitioners should review the evidence for the specific product they choose

Where do polynucleotides fit in?

Polynucleotides (PN) are chains of nucleotides, often derived from salmon or trout DNA, used to support tissue repair, hydration and skin quality. They’re often described as “bio-regenerators” or “bio-revitalisers”, and some clinics group them with biostimulators. However, their mechanism is generally described as supporting fibroblast activity and tissue repair rather than triggering a foreign-body-type response. Whether they belong under the “biostimulator” label depends on who you ask, so it’s worth being clear with patients about what a product does and doesn’t do.

Biostimulators vs Dermal Fillers: What’s the Difference?

The two aren’t rivals. Many practitioners combine them, using HA fillers for shaping and biostimulators for foundation and skin quality, in whatever order and timing suits the patient.

Potential Benefits

• Improved skin quality and firmness through new collagen production
• Subtle, gradual results that many patients find look natural
• Longer-lasting outcomes compared with many HA fillers
• Versatility, with uses across the face, neck, décolletage and body depending on the product and its licensing

Limitations and Risks to Be Honest About

An unbiased look at biostimulators has to include the downsides:

1. Results take time. Patients expecting an instant change may be disappointed.
2. Results can be less predictable. Because the outcome depends on each patient’s biological response, results vary more than with a simple volumising filler.
3. Reversibility is limited. Unlike HA, most biostimulators can’t be quickly dissolved with a single enzyme. Although some approaches have been suggested for certain products, the evidence is limited, so prevention through correct technique and patient selection matters more.
4. Nodules and lumps. Delayed-onset nodules are a recognised complication, particularly with incorrect placement, dilution or technique.
5. Vascular complications. As with any injectable, there’s a risk of vascular occlusion if product enters a vessel. Anatomical knowledge and safe injection technique are non-negotiable.
6. Common short-term effects. Swelling, bruising, tenderness and redness can occur after treatment.
7. Evidence varies. Some products have extensive clinical data. Others have more limited long-term evidence. Practitioners should check what’s available for each one.
8. Not suitable for everyone. Active infection, certain autoimmune conditions, pregnancy and breastfeeding, and a history of certain allergic reactions or scarring tendencies are among the considerations. Always follow the manufacturer’s instructions for use and your professional guidance.

Who Are Biostimulators Suitable For?

Suitability is a clinical judgement, made on a case-by-case basis. In general, biostimulators are discussed for patients who:

• Have mild to moderate skin laxity or early volume loss
• Want gradual, natural-looking improvement
• Are happy to wait for results and, where needed, attend multiple sessions
• Have realistic expectations and no contraindications

They may be less suitable for patients who want an immediate, sculpted result, or who would be uncomfortable with the limited reversibility.

Tips for Practitioners Considering Biostimulators

1. Get properly trained. Product-specific training in anatomy, depth, dilution and complication management is essential.
2. Read the manufacturer’s instructions for use and understand what’s on-label and off-label.
3. Have a complication plan. Know how you’d recognise and manage nodules, vascular compromise and other adverse events before you need to.
4. Take thorough consultations and consent. Explain timelines, the possibility of multiple sessions, limited reversibility and realistic outcomes.
5. Keep records. Document batch numbers, dilution, depth, volume and patient response.
6. Check your insurance and regulatory position. Requirements can change, so make sure your cover and practice meet current UK requirements.
7. Source from reputable suppliers. Genuine, correctly stored, properly documented products matter for both patient safety and traceability.

Frequently Asked Questions

Are biostimulators the same as dermal fillers?

Not exactly. Many fillers work by adding volume directly, while biostimulators work by prompting the skin to produce its own collagen. Some products, such as certain CaHA and PCL formulations, do both to some extent.

How long do biostimulator results last?

It depends on the product, the treated area, the dose and the individual. Some last around a year or so, while others are reported to last two years or more.

How soon will patients see results?

Usually gradually over several weeks to months, as collagen builds up. Some products give a small initial effect from the carrier gel.

Can biostimulators be dissolved?

Generally not in the way HA fillers can be dissolved with hyaluronidase. That’s why technique and patient selection are so important.

Do biostimulators hurt?

Discomfort is usually manageable and depends on the area, the product and the technique. Many practitioners use topical anaesthetic, and some products contain local anaesthetic.

Can biostimulators be combined with other treatments?

Practitioners often combine them with HA fillers, skin boosters or other treatments, but the timing and order should follow clinical judgement and each product’s guidance.

Are polynucleotides biostimulators?

It depends on how the term is used. Polynucleotides support tissue repair and skin quality, but they work differently from PLLA, CaHA, PCL or PDLLA, so many practitioners classify them separately as bio-regenerators.

Final Thoughts

Biostimulators are a genuinely useful addition to the aesthetic toolkit, but they aren’t a magic solution. They suit patients who want gradual, natural-looking improvement in skin quality and structure, and they reward practitioners who invest in training, careful technique and honest consultations. They also come with real limitations, from slower results to limited reversibility, and those deserve just as much attention as the benefits.

If you’re deciding whether to add biostimulators to your practice, take time to compare products, review the clinical evidence, and think about which patients you’re treating and what outcomes they want.

Disclaimer: This article is for general information for qualified practitioners and isn’t medical advice. Always follow manufacturer instructions, current UK regulations and your professional guidance.